cohort,subgroup,patient_count,avg_medication_complexity,avg_los_days,mortality_rate
Age-Matched Control (48-58 F),All Patients,44747,15.73,4.34,0.011
Age-Matched Control (48-58 F),Interaction Risk (>=2 Sero. Drugs),10850,22.76,5.49,0.0128
Age-Matched Control (48-58 F),No/Low Interaction Risk (<2 Sero. Drugs),33897,13.48,3.97,0.0104
Hemorrhagic Stroke (48-58 F),All Patients,496,23.46,10.74,0.123
Hemorrhagic Stroke (48-58 F),Interaction Risk (>=2 Sero. Drugs),140,27.96,11.72,0.0857
Hemorrhagic Stroke (48-58 F),No/Low Interaction Risk (<2 Sero. Drugs),356,21.69,10.36,0.1376
Hemorrhagic Stroke (48-58 F),Top 25% Complexity (Quartile 1),124,35.46,16.48,0.2016
